Page last updated: 2024-11-02

piracetam and Muscle Spasticity

piracetam has been researched along with Muscle Spasticity in 7 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Muscle Spasticity: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a free interval) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)

Research Excerpts

ExcerptRelevanceReference
" focuses on the current clinical development of the antiepileptic drug levetiracetam for amyotrophic lateral sclerosis."7.73Clinical development of levetiracetam for amyotrophic lateral sclerosis. ( Davies, SL; Moral, MA, 2006)
"Levetiracetam was well tolerated."6.74Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009)
"Levetiracetam was effective for reducing phasic spasticity but not tonic spasticity in this 12-patient case series."5.32Levetiracetam for phasic spasticity in multiple sclerosis. ( Frohman, E; Hawker, K; Racke, M, 2003)
" focuses on the current clinical development of the antiepileptic drug levetiracetam for amyotrophic lateral sclerosis."3.73Clinical development of levetiracetam for amyotrophic lateral sclerosis. ( Davies, SL; Moral, MA, 2006)
"Levetiracetam was well tolerated."2.74Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009)
"Levetiracetam was effective for reducing phasic spasticity but not tonic spasticity in this 12-patient case series."1.32Levetiracetam for phasic spasticity in multiple sclerosis. ( Frohman, E; Hawker, K; Racke, M, 2003)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedlack, RS1
Pastula, DM1
Hawes, J1
Heydt, D1
Osman, NI1
Lorincz, MT1
Hulsing, KL1
Gebarski, SS1
Hawker, K1
Frohman, E1
Racke, M1
Rüegg, SJ1
Steck, AJ1
Fuhr, P1
Zafonte, R1
Lombard, L1
Elovic, E1
Davies, SL1
Moral, MA1
Maritz, NG1
Müller, FO1
Pompe van Meerdervoort, HF1

Reviews

1 review available for piracetam and Muscle Spasticity

ArticleYear
Antispasticity medications: uses and limitations of enteral therapy.
    American journal of physical medicine & rehabilitation, 2004, Volume: 83, Issue:10 Suppl

    Topics: 4-Aminopyridine; Acetates; Adrenergic alpha-Agonists; Amines; Baclofen; Benzodiazepines; Cyclohexane

2004

Trials

2 trials available for piracetam and Muscle Spasticity

ArticleYear
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2009, Volume: 10, Issue:4

    Topics: Adult; Aged; Anticonvulsants; Disease Progression; Humans; Levetiracetam; Middle Aged; Motor Neuron

2009
Piracetam in the management of spasticity in cerebral palsy.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1978, Jun-03, Volume: 53, Issue:22

    Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; Evaluation Studies as

1978

Other Studies

4 other studies available for piracetam and Muscle Spasticity

ArticleYear
Leukoencephalopathy, cerebral calcifications, and cysts: case report.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:6

    Topics: Adult; Anticonvulsants; Basal Ganglia Diseases; Brain; Calcinosis; Central Nervous System Cysts; Dys

2012
Levetiracetam for phasic spasticity in multiple sclerosis.
    Archives of neurology, 2003, Volume: 60, Issue:12

    Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Middl

2003
Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome.
    Neurology, 2004, Jan-27, Volume: 62, Issue:2

    Topics: Female; GABA Agonists; Humans; Immunoglobulins, Intravenous; Levetiracetam; Middle Aged; Muscle Spas

2004
Clinical development of levetiracetam for amyotrophic lateral sclerosis.
    Drug news & perspectives, 2006, Volume: 19, Issue:9

    Topics: Amyotrophic Lateral Sclerosis; Animals; Anticonvulsants; Clinical Trials as Topic; Humans; Levetirac

2006